SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?


To: marginmike who wrote (190326)9/3/2002 3:23:50 PM
From: Bid Buster  Respond to of 436258
 
why?..the law of nature states all clowns will be destroyed <G>



To: marginmike who wrote (190326)9/4/2002 2:01:49 PM
From: Box-By-The-Riviera™  Read Replies (1) | Respond to of 436258
 
save martha

story.news.yahoo.com



To: marginmike who wrote (190326)9/10/2002 7:17:52 PM
From: maceng2  Respond to of 436258
 
The end of life as we know it...

ananova.com

ROUNDUP US House panel recommends Justice Dept investigate Martha Stewart

The House Energy and Commerce Committee recommended that the US Justice Department investigate Martha Stewart for her statements to the committee regarding alleged insider trading in a Dec 2001 stock trade involving ImClone Systems Inc.

"It is with disappointment we announce, obviously, that we have come to the end of the road in regard to the matter dealing with Martha Stewart and that it is now up to the Justice Department to make judgments in the matter," said Louisiana Republican WJ "Billy" Tauzin, chairman of the House Energy and Commerce Committee.

The committee said it decided against forcing Stewart to testify before the panel because she had told the committee that she would refuse to answer questions under her rights afforded her by the fifth amendment of the US constitution.

In a statement issued shortly after the announcement, Stewart's lawyers said they "strongly disagree" with the findings of the panel.

"I strongly disagree with the analysis of the committee and its staff, but am pleased that the matter will now be exclusively in the hands of professional law enforcement authorities who are trained to conduct a responsible and thorough investigation," attorney Robert Morvillo said.

The lifestyle guru, who runs Martha Stewart Living Omnimedia Inc, has come under fire for selling some 4,000 ImClone shares on Dec 27, a day before ImClone's 'Erbitux' cancer drug was rejected by the Food and Drug Administration.

ImClone is developing the cancer treatment with Bristol-Myers Squibb Co.

But the former Wall Street stockbroker initially said she had placed a a stop-loss order with her Merrill Lynch & Co broker Peter Bacanovic, to sell the stock when it dipped below $60.00. In June, an assistant to Bacanovic, Douglas Faneuil, said no such order was in place.

Lawmakers have questioned her story and repeatedly sought to have Stewart explain her story under questioning by committee staff. Stewart has refused and instead turned over documents related to the transaction.

Those documents have not appeased the lawmakers, who recommended that the DoJ investigate the television personality, who could end up in prison for up to 5 years if she is prosecuted and convicted. "This evidence raises a serious question as to whether Ms. Stewart's accounts were false, misleading and designed to conceal material facts," Tauzin said, adding that the committee had not made a conclusion as to whether Stewart's actions constitute a federal crime.

The head of the Energy and Commerce Subcommittee on Oversight and Investigations, Rep. James Greenwood, a Pennsylvania Republican, said the committee would continue its investigation of current ImClone CEO, Harlan Waksal, the brother of indicted former chief executive officer Sam Waksal.

"We are still looking at the question of what Harlan Waksal has said to us and whether we believe that everything he has said to us when he did come and testify before our committee, whether ... we believe that what he said was all the truth as well," Greenwood said.

Sam Waksal, who is a friend of Stewart's, has been charged with insider trading, bank fraud, obstruction of justice and perjury in relation to his alleged efforts to dump the stock in December.

Greenwood stressed that Stewart is not a central player in the scandal.

"I think it's important that it be understood that this is a side show in this investigation of ImClone, this is a side show in the investigation of corporate responsibility, it is a side show in the investigation of how FDA does its work," Greenwood said.